OTC Competitor Cost Structures USA
Kline’s syndicated analysis of the profitability and
cost structures of ten leading OTC drug companies in the United States.
Company profiles included in this report features overviews
of each company’s OTC business unit; an assessment of domestic
OTC sales by product class; and an analysis of costs, expenses, and
profitability by company and by product class.
2010 Edition Please click for full description
To be launched May 2010
To be published 4th qtr. 2010
2006 Edition Please click for full description
Published October 2006
2001 Edition Please click for full description
Published May 2002
 |